Company intelligence / Profile preview
PearlsInMires
South Koreaen.pearlsinmires.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PearlsInMires conducts systematic R&D for new drug candidates with a focus on oncology. The company collaborates with major research institutes, CROs, and university hospitals to develop key items and secure high-quality clinical data across all phases of development. It also partners globally for technology transfer of its main assets.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Collaborates with major national research institutesCROsleading university hospitalspartners with a global business development company based in the United States for technology transferconnects with global pharmaceutical companies through open innovation programs
Beyond the preview
Go deeper on PearlsInMires.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PearlsInMires.